Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
about
Hypothetical Atopic Dermatitis-Myeloproliferative Neoplasm SyndromeProtein tyrosine phosphatases as wardens of STAT signalingPhosphoinositides: tiny lipids with giant impact on cell regulationKinetic Scaffolding Mediated by a Phospholipase C- and Gq Signaling ComplexThe phospholipase C isozymes and their regulationAssociation of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cellsAssociation of activated Gαq to the tumor suppressor Fhit is enhanced by phospholipase CβShort Stat5-interacting peptide derived from phospholipase C-β3 inhibits hematopoietic cell proliferation and myeloid differentiationTET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia.Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease.IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells.Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1Phospholipase C-β in immune cells.Critical role for mast cell Stat5 activity in skin inflammationDual-Specificity Phosphatase 4 Regulates STAT5 Protein Stability and Helper T Cell Polarization.Phosphoinositide-specific phospholipase C in health and disease.DUSP4 deficiency enhances CD25 expression and CD4+ T-cell proliferation without impeding T-cell development.Shp1 regulates T cell homeostasis by limiting IL-4 signalsRegulation of retinal angiogenesis by phospholipase C-β3 signaling pathwayStructural insights into phospholipase C-β function.Roles of phospholipase C isozymes in organogenesis and embryonic development.Immune regulation by phospholipase C-β isoforms.Nuclear phosphoinositide regulation of chromatin.Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease.Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cellsEpidermal phospholipase Cδ1 regulates granulocyte counts and systemic interleukin-17 levels in mice.PLCD3, a flotillin2-interacting protein, is involved in proliferation, migration and invasion of nasopharyngeal carcinoma cells.cAMP signalling of Bordetella adenylate cyclase toxin through the SHP-1 phosphatase activates the BimEL-Bax pro-apoptotic cascade in phagocytes.Protein Tyrosine Phosphatases as Potential Regulators of STAT3 SignalingPositive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding ProteinProtein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease
P2860
Q26784465-064ECB85-F925-47A1-BD1C-8CBDD6D64EA0Q26861574-3646E3D8-3E8A-4530-AAE5-32162175A351Q27012953-DFDE4E7D-6BAB-4D8E-91F6-B4BA2267A643Q27665290-655C699F-4FC8-4BCE-B208-5E5CC5918573Q28261474-11195EA0-9FAD-48C9-8A7C-12FE00F50372Q28744086-85F2419E-4299-4333-BB55-C72DFBA2F5E0Q30670527-15D20BD7-316B-491D-A72D-753A58F6FD6CQ34031781-7B9F982F-A4B9-4B3D-A897-E79CFD6C0C63Q34157339-74A6B853-1095-4530-9831-5B114A86ECF7Q34541593-DCEC8394-25B0-495E-B356-958A6AEDED4CQ34651540-FD7F1137-ADDE-4308-B236-66D2D489A381Q35072220-5A7CDA29-EF9C-44FA-BE2F-4EBB7342FAC6Q35073385-EC4F8B56-6970-4DF7-BD85-5B7B1FB1ADDDQ35087816-FE7767AD-8857-4F5E-ACB4-457060B83944Q35879703-DB48150E-95C1-4917-8E3A-905C08DCC89DQ36093239-B09624FF-E357-43E9-B85F-65F1DC36785CQ36453016-AEB7441E-4F70-4464-A242-E6645732BA3CQ36973659-99D49A72-3DB5-4B9F-931B-8B7DD3D8B8B1Q37057695-2B7617E6-353D-46BF-8A70-33BA628BF0C0Q37193142-644B38B5-C9BC-4ED8-B451-37603B2E70B6Q37649262-33DEA353-12CC-443E-A645-3548314402C2Q38013658-45AE05B5-3529-42BE-A666-99B1D24C7678Q39159757-9C49D99A-F9A8-415B-9B16-CCFEBD74BA05Q40834797-78CB8304-19A1-4074-8E4C-EDEC95A7E154Q41772561-85AF3202-5610-43E6-8080-40A23DDC7BE0Q42832660-0AB3FB3A-05BE-48BD-A34C-06F1EDCA034DQ47426837-6877969E-DF9C-4826-AD91-2402D7D8CABAQ55043889-4C27A165-550E-48CE-81DB-6E4FA4EE6008Q58749617-A216FA99-289D-424C-934E-A82D94079601Q58803454-C1218051-9229-4A01-A581-77FC24DC5D42Q59133604-0072601B-8CFF-408F-9F53-F4859A211CFD
P2860
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
@ast
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
@en
type
label
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
@ast
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
@en
prefLabel
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
@ast
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
@en
P2093
P2860
P1433
P1476
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5
@en
P2093
Akiko Kimura
Anargyros Xenocostas
Atsushi Iwama
Cyrus C Hsia
Dianqing Wu
Hiroki Yasudo
Hiromi Kubagawa
Hiromitsu Nakauchi
Joaquin Madrenas
P2860
P304
P356
10.1016/J.CCR.2009.05.018
P577
2009-08-01T00:00:00Z